小结
撰稿人
作者
Stephen L. Atkin, PhD, FRCP
Professor of Medicine
Weill Cornell Medical College Qatar
Qatar Foundation
Education City
Doha
Qatar
利益声明
SLA has received funds for an investigator-initiated study from Novo Nordisk and is also an educational speaker for the company.
Thozhukat Sathyapalan, MD, MRCP FRCPE
Professor of Endocrinology/Honorary Consultant Endocrinologist
Academic Endocrinology, Diabetes and Metabolism
Hull York Medical School
Michael White Diabetes Centre
Hull Royal Infirmary
Hull
UK
利益声明
TS declares that he has no competing interests.
鸣谢
Dr Stephen L. Atkin and Dr Thozhukat Sathyapalan would like to gratefully acknowledge Dr Shehzad Basaria and Dr Milena Braga-Basaria, the previous contributors to this topic. SB and MBB declare that they have no competing interests.
同行评议者
Joe McKenna, MD
Professor of Investigative Endocrinology
University College
Dublin
Ireland
利益声明
JM declares that he has no competing interests.
Udaya Kabadi, MD, FRCP(C), FACP, FACE
Director
Endocrinology
Department of Internal Medicine
VA Medical Center
University of Iowa
Iowa City
IA
利益声明
UK declares that he has no competing interests.
内容使用需遵循免责声明